332 related articles for article (PubMed ID: 15609309)
1. 5-Aza-2'-deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemia.
Schmelz K; Wagner M; Dörken B; Tamm I
Int J Cancer; 2005 May; 114(5):683-95. PubMed ID: 15609309
[TBL] [Abstract][Full Text] [Related]
2. Decitabine activates specific caspases downstream of p73 in myeloid leukemia.
Tamm I; Wagner M; Schmelz K
Ann Hematol; 2005 Dec; 84 Suppl 1():47-53. PubMed ID: 16193303
[TBL] [Abstract][Full Text] [Related]
3. TAp73 and ΔNp73 have opposing roles in 5-aza-2'-deoxycytidine-induced apoptosis in breast cancer cells.
Lai J; Yang F; Zhang W; Wang Y; Xu J; Song W; Huang G; Gu J; Guan X
Mol Cells; 2014 Aug; 37(8):605-12. PubMed ID: 25134538
[TBL] [Abstract][Full Text] [Related]
4. Induction of gene expression by 5-Aza-2'-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanisms.
Schmelz K; Sattler N; Wagner M; Lübbert M; Dörken B; Tamm I
Leukemia; 2005 Jan; 19(1):103-11. PubMed ID: 15510208
[TBL] [Abstract][Full Text] [Related]
5. 5-aza-2'-deoxycytidine activates the p53/p21Waf1/Cip1 pathway to inhibit cell proliferation.
Zhu WG; Hileman T; Ke Y; Wang P; Lu S; Duan W; Dai Z; Tong T; Villalona-Calero MA; Plass C; Otterson GA
J Biol Chem; 2004 Apr; 279(15):15161-6. PubMed ID: 14722112
[TBL] [Abstract][Full Text] [Related]
6. 5-Aza-2'-deoxycytidine increases the sensitivity of human bone marrow mesenchymal stem cells to chemotherapeutic agents by demethylation of p73.
Liang W; Xia H; Li J; Chunhua Zhao R
J Pediatr Hematol Oncol; 2012 Mar; 34(2):108-15. PubMed ID: 22278203
[TBL] [Abstract][Full Text] [Related]
7. Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2'-deoxycytidine.
Karpf AR; Moore BC; Ririe TO; Jones DA
Mol Pharmacol; 2001 Apr; 59(4):751-7. PubMed ID: 11259619
[TBL] [Abstract][Full Text] [Related]
8. p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a DNA hypomethylation-independent decitabine gene target that correlates with clinical response in myelodysplastic syndrome/acute myelogenous leukemia.
Link PA; Baer MR; James SR; Jones DA; Karpf AR
Cancer Res; 2008 Nov; 68(22):9358-66. PubMed ID: 19010910
[TBL] [Abstract][Full Text] [Related]
9. Activation of p53/p21Waf1/Cip1 pathway by 5-aza-2'-deoxycytidine inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells.
Pulukuri SM; Rao JS
Int J Oncol; 2005 Apr; 26(4):863-71. PubMed ID: 15753979
[TBL] [Abstract][Full Text] [Related]
10. Identification of hypermethylation in hepatocyte cell adhesion molecule gene promoter region in bladder carcinoma.
Tao J; Liu Q; Wu X; Xu X; Zhang Y; Wang Q; Luo C
Int J Med Sci; 2013; 10(13):1860-7. PubMed ID: 24324362
[TBL] [Abstract][Full Text] [Related]
11. 5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation.
Scott SA; Dong WF; Ichinohasama R; Hirsch C; Sheridan D; Sanche SE; Geyer CR; Decoteau JF
Leuk Res; 2006 Jan; 30(1):69-76. PubMed ID: 16043219
[TBL] [Abstract][Full Text] [Related]
12. Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinoma.
Kang MJ; Park BJ; Byun DS; Park JI; Kim HJ; Park JH; Chi SG
Clin Cancer Res; 2000 May; 6(5):1767-71. PubMed ID: 10815895
[TBL] [Abstract][Full Text] [Related]
13. Activation of expression of p15, p73 and E-cadherin in leukemic cells by different concentrations of 5-aza-2'-deoxycytidine (Decitabine).
Farinha NJ; Shaker S; Lemaire M; Momparler L; Bernstein M; Momparler RL
Anticancer Res; 2004; 24(1):75-8. PubMed ID: 15015578
[TBL] [Abstract][Full Text] [Related]
14. [Growth and gene expression of leukemia cell after treated with methylation inhibitor 5-aza-2'-deoxycytidine].
Qiao SK; Xu SR; Guo XN
Zhonghua Xue Ye Xue Za Zhi; 2004 Aug; 25(8):486-90. PubMed ID: 15555266
[TBL] [Abstract][Full Text] [Related]
15. An ATM- and Rad3-related (ATR) signaling pathway and a phosphorylation-acetylation cascade are involved in activation of p53/p21Waf1/Cip1 in response to 5-aza-2'-deoxycytidine treatment.
Wang H; Zhao Y; Li L; McNutt MA; Wu L; Lu S; Yu Y; Zhou W; Feng J; Chai G; Yang Y; Zhu WG
J Biol Chem; 2008 Feb; 283(5):2564-74. PubMed ID: 17977830
[TBL] [Abstract][Full Text] [Related]
16. Consequences of combining siRNA-mediated DNA methyltransferase 1 depletion with 5-aza-2'-deoxycytidine in human leukemic KG1 cells.
Vispé S; Deroide A; Davoine E; Desjobert C; Lestienne F; Fournier L; Novosad N; Bréand S; Besse J; Busato F; Tost J; De Vries L; Cussac D; Riond J; Arimondo PB
Oncotarget; 2015 Jun; 6(17):15265-82. PubMed ID: 25948775
[TBL] [Abstract][Full Text] [Related]
17. [Effect of 5-aza-2'-deoxycytidine on cell of high-risk patients with myelodysplastic syndrome in vitro].
Tong HY; Lin MF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Aug; 12(4):467-71. PubMed ID: 15363133
[TBL] [Abstract][Full Text] [Related]
18. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH
Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793
[TBL] [Abstract][Full Text] [Related]
19. Possible involvement of activation of P53/P21 and demethylation of RUNX 3 in the cytotoxicity against Lovo cells induced by 5-Aza-2'-deoxycytidine.
Deng T; Zhang Y
Life Sci; 2009 Feb; 84(9-10):311-20. PubMed ID: 19159630
[TBL] [Abstract][Full Text] [Related]
20. Pleomorphic adenoma gene-like 2 regulates expression of the p53 family member, p73, and induces cell cycle block and apoptosis in human promonocytic U937 cells.
Hanks TS; Gauss KA
Apoptosis; 2012 Mar; 17(3):236-47. PubMed ID: 22076304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]